Retour
  1. Accueil
  2. Profil de Anne Trelcat (UMONS)
Profil

Trelcat Anne

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service d'Anatomie humaine et Oncologie expérimentale

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chirurgie

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Cardiologie

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Anatomie humaine et Oncologie expérimentale

Principaux co-auteurs référencés
JOURNE, Fabrice  (11)
SAUSSEZ, Sven  (8)
CARLIER, Stéphane  (6)
Kindt, Nadège (5)
Scalia, Alessandro  (5)
Principaux mots-clés référencés
Molecular Biology (3); oxLDL (3); atherosclerosis (2); Cancer Research (2); head and neck cancer (2);
Principales disciplines référencées
Oncologie (8)
Systèmes cardiovasculaire & respiratoire (5)
Chimie (2)
Pharmacie, pharmacologie & toxicologie (1)
Anatomie (cytologie, histologie, embryologie...) & physiologie (1)

Publications (14)

La plus téléchargée
57 téléchargements
Kindt, N., Journe, F., Carlier, S., Trelcat, A., Scalia, A., & Saussez, S. (05 May 2021). Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas. Biomedicines, 9 ((5)), 513. https://hdl.handle.net/20.500.12907/30991

La plus citée

46 citations (Scopus®)

Descamps, G., Verset, L., Trelcat, A., Hopkins, C., Lechien, J., Journe, F., & Saussez, S. (2020). ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection. Biology. https://hdl.handle.net/20.500.12907/11166

Scalia, A., Coquay, M., Kindt, N., DUEZ, P., Aro, R., JOURNE, F., Fabjanczyk, M., Trelcat, A., & CARLIER, S. (31 August 2024). In Vitro Modulation of Human Foam Cell Formation and Adhesion Molecules Expression by Ginger Extracts Points to Potential Cardiovascular Preventive Agents. International Journal of Molecular Sciences, 25 (17), 9487. doi:10.3390/ijms25179487
Peer reviewed vérifié par ORBi

Mhaidly, N., Barake, N., Trelcat, A., JOURNE, F., SAUSSEZ, S., & DESCAMPS, G. (01 August 2024). Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway. Cancers, 16 (15), 2739. doi:10.3390/cancers16152739
Peer reviewed vérifié par ORBi

Kindt, N., Thayse, K., Dalil, N., Trelcat, A., & Carlier, S. (May 2024). Does female sex matter in a chronic intermittent hypoxia mouse model? Journal of Molecular and Cellular Cardiology, 190, 76 - 78. doi:10.1016/j.yjmcc.2024.04.005
Peer reviewed vérifié par ORBi

Soumoy, L., Genbauffe, A., Mouchart, L., Sperone, A., Trelcat, A., Mukeba-Harchies, L., Wells, M., Blankert, B., Najem, A., Ghanem, G., Saussez, S., & Journe, F. (04 January 2024). ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy. Cancer Cell International, 24 (1), 8. doi:10.1186/s12935-023-03196-y
Peer reviewed vérifié par ORBi

Mhaidly, N., Journe, F., Najem, A., Stock, L., Trelcat, A., Dequanter, D., SAUSSEZ, S., & DESCAMPS, G. (15 August 2023). Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell-Macrophage Interactions Using Three-Dimensional Coculture Models. International Journal of Molecular Sciences, 24 (16), 12813. doi:10.3390/ijms241612813
Peer reviewed vérifié par ORBi

Scalia, A., Doumani, L., Kindt, N., Journe, F., Trelcat, A., & Carlier, S. (22 June 2023). The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers. Biology, 12 (7), 896. doi:10.3390/biology12070896
Peer reviewed vérifié par ORBi

Scalia, A., Kindt, N., Trelcat, A., Nachtergael, A., Duez, P., Journe, F., & Carlier, S. (19 October 2022). Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells. International Journal of Molecular Sciences, 23 (20), 12552. doi:10.3390/ijms232012552
Peer reviewed vérifié par ORBi

Scalia, A., Kindt, N., Trelcat, A., Nachtergael, A., Duez, P., & Carlier, S. (10 February 2022). Development of 'home-made' oxLDL to study the interplay between atherosclerosis and cancer: characterization of their effects on head and neck cancer cells [Paper presentation]. Belgian Society of Cardiology Meeting, Bruxelles, Belgium.

Gheysen, L., Soumoy, L., Trelcat, A., Verset, L., Journe, F., & Saussez, S. (2021). New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer. Cells.
Peer reviewed vérifié par ORBi

Kindt, N., Journe, F., Carlier, S., Trelcat, A., Scalia, A., & Saussez, S. (05 May 2021). Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas. Biomedicines, 9 ((5)), 513.
Peer reviewed vérifié par ORBi

Descamps, G., Verset, L., Trelcat, A., Hopkins, C., Lechien, J., Journe, F., & Saussez, S. (2020). ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection. Biology.
Peer reviewed vérifié par ORBi

Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies [Poster presentation]. BACR Annual meeting, Jette, Belgium.

Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies [Poster presentation]. 14th meeting of the FRS-FNRS Contact group on Oxidative Proceses and Antioxidants, UMONS, Belgium.

Gheysen, L., Descamps, G., Seminerio, I., Furgiuele, S., Soumoy, L., & Trelcat, A. (2019). Wonder Researchers , Communication audiovisuelle, Journée des doctorants, Mons, 2019.

Contacter ORBi UMONS